Steven R. Goodman, Ph.D. serves as Vice Chancellor for Research at The University of Tennessee Health Science Center (UTHSC) where he also serves as Professor in the Departments of Pediatrics and Physiology in the College of Medicine; with additional appointments in the College of Dentistry, College of Graduate of Health Sciences, College of Health Professions, College of Nursing, and College of Pharmacy. Steve is based at the UTHSC campus in Memphis but has oversight of Research activities at all UTHSC campuses including Chattanooga, Knoxville and Nashville. Dr. Goodman has led creation of the UTHSC Operational Strategic Plan for Research, the Allocation of Research Space Plan, Institutional Core Business Plans and the Tennessee Clinical Trials Network (CTN2). Steve currently serves as the President and CEO of CTN2. He also created the Collaborative Research Network which has provided CORNET grant awards to stimulate new research collaborations within UTHSC, between UTHSC and other University’s and throughout the UT system.
Steve is known globally for his four decades of research into the structure and function of cell structures called membrane skeletons. His related research into sickle cell disease led to defining the molecular basis of the irreversibly sickle cell and his recent proteomic studies led to potential biomarkers for sickle cell severity. He has published over 160 peer reviewed research articles, review articles and book chapters and another 130 scientific meeting abstracts. Steve’s research has garnered over 20 million dollars of extramural support. Dr. Goodman’s research accomplishments have led to his becoming a recipient of the Society of Experimental Biology and Medicine (SEBM) Distinguished Scientist Award and his election as a 2016 American Association for the Advancement of Science (AAAS) Fellow.
Steve is a Past President of the Association of Anatomy, Cell Biology and Neurobiology Chairs (AACBNC). The 4th Edition of his textbook, Goodman’s Medical Cell Biology, just became available in July 2020. Dr. Goodman serves on multiple editorial boards and has been Editor-in-Chief of Experimental Biology and Medicine (EBM) since July 2006. Since becoming Editor-in-Chief of EBM, Dr. Goodman has globalized SEBM and EBM opening offices in Tainan, Taiwan, London, England, Chengdu, China, Campinas, Brazil, and most recently Ghana Africa. These are in addition to the SEBM office in the Washington DC area and the EBM office in Texas.